These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2011095)
1. Rhabdomyosarcoma of the larynx in children: a series of five patients treated in the Institut Gustave Roussy (Villejuif, France). Kato MA; Flamant F; Terrier-Lacombe MJ; Habrand JL; Schwaab G; Luboinski B; Valteau-Couanet D; Lemerle J Med Pediatr Oncol; 1991; 19(2):110-4. PubMed ID: 2011095 [TBL] [Abstract][Full Text] [Related]
2. Therapy of rhabdomyosarcoma of the larynx. Gross M; Gutjahr P Int J Pediatr Otorhinolaryngol; 1988 Feb; 15(1):93-7. PubMed ID: 3372146 [TBL] [Abstract][Full Text] [Related]
3. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Paulino AC; Simon JH; Zhen W; Wen BC Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653 [TBL] [Abstract][Full Text] [Related]
4. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results. Flamant F; Rodary C; Voute PA; Otten J Radiother Oncol; 1985 Apr; 3(3):227-36. PubMed ID: 3890032 [TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyosarcoma: therapeutic results and prospectives]. Guglielmi M; Carli M Pediatr Med Chir; 1984; 6(2):179-84. PubMed ID: 6549408 [TBL] [Abstract][Full Text] [Related]
7. Perianal alveolar rhabdomyosarcoma in a child. Report of a long-term survival case. Mihara S; Yano H; Matsumoto H; Hiyoshi Y; Nohara M; Morimatsu M Dis Colon Rectum; 1983 Nov; 26(11):728-31. PubMed ID: 6354645 [TBL] [Abstract][Full Text] [Related]
8. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan AA; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS J Clin Oncol; 2014 Nov; 32(31):3547-52. PubMed ID: 25267746 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital]. Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704 [TBL] [Abstract][Full Text] [Related]
10. Conservative treatment for lower gynecological tract malignancies in children and adolescents: the Institut Gustave-Roussy experience. Gerbaulet AP; Esche BA; Haie CM; Castaigne D; Flamant F; Chassagne D Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):655-8. PubMed ID: 2777654 [TBL] [Abstract][Full Text] [Related]
11. [Pediatric rhabdomyosarcoma of the infratemporal fossa]. Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115 [TBL] [Abstract][Full Text] [Related]
12. Genital rhabdomyosarcoma: current management and review of the literature. Bell J; Averette H; Davis J; Toledano S Obstet Gynecol Surv; 1986 May; 41(5):257-63. PubMed ID: 3517719 [TBL] [Abstract][Full Text] [Related]
13. Modern treatment of vaginal embryonal rhabdomyosarcoma. Friedman M; Peretz BA; Nissenbaum M; Paldi E Obstet Gynecol Surv; 1986 Oct; 41(10):614-8. PubMed ID: 3534662 [No Abstract] [Full Text] [Related]
14. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy for laryngeal rhabdomyosarcoma. DeGroot TR; Frazer JP; Wood BP Am J Otolaryngol; 1980 Nov; 1(5):456-60. PubMed ID: 6161551 [TBL] [Abstract][Full Text] [Related]
16. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
17. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200 [TBL] [Abstract][Full Text] [Related]
19. The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma. Etcubanas E; Rao BN; Kun LE; Horowitz ME; Parham DM; Hustu HO; Green AA Arch Surg; 1987 Dec; 122(12):1451-4. PubMed ID: 3689122 [TBL] [Abstract][Full Text] [Related]
20. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. McDowell HP; Foot AB; Ellershaw C; Machin D; Giraud C; Bergeron C Eur J Cancer; 2010 Jun; 46(9):1588-95. PubMed ID: 20338746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]